Arthritis, Musculoskeletal and Skin Diseases Research — CFDA 93.846

Musculoskeletal-research obligations at $4.32 billion

USAspending.gov records $4,315,511,081.33 in obligations under CFDA 93.846. Two thousand six hundred eighty-three awards produce that stock. A simple average is about $1.61 million per award — typical of multi-year biomedical research grants rather than state block grants. That average is a quotient of two packet totals, not a typical project budget.

The assistance-listing title is ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH. CFDA 93.846 is the identifier. Other health-research listings, if tagged under other CFDA numbers, are not included in the $4.32 billion. Mixing those codes would invent a combined rheumatology total this packet does not contain.

365 recipients across 44 states

Three hundred sixty-five recipients share 2,683 awards, or about 7.4 award records per recipient on average. Splitting $4.32 billion evenly would assign about $11.8 million per recipient. That pattern matches a research portfolio in which institutions hold multiple awards. The packet does not list the 365. Recipient count is the organizational headcount, not a census of investigators.

Forty-four states in the geographic count show broad coding without covering every coded jurisdiction. Research dollars still concentrate at large biomedical campuses. The state count does not flatten those differences. Place-of-performance amounts are on the program table.

Award rows are not a patient census

Among research listings, 93.846 is a mid-density file: 2,683 rows against 365 recipients. Renewals and supplements can inflate award count relative to unique projects. Award count is therefore a weak proxy for “number of arthritis studies.” Recipients (365) tell you how many named organizations sit on the extract; awards (2,683) tell you how many assistance rows were stored.

The packet does not report trial enrollments, clinic visits, or publication counts. Citing 2,683 as patients or papers would be a unit error. Keep the units straight: dollars, awards, recipients, states.

Obligations versus research outlays

The $4.32 billion is an obligation total from USAspending.gov. Outlays — cash paid against musculoskeletal-research awards — are not in the packet. A laboratory can show a large obligation stock while draws follow a multi-year grant calendar. Deobligations and upward adjustments both move the total. A remaining-balance question is an outlay question this extract does not answer.

Use CFDA 93.846 to size the Arthritis, Musculoskeletal and Skin Diseases Research listing in the assistance file. Do not use it as a clinical-outcomes dashboard. Those series live elsewhere. This page reports the obligation book tagged 93.846.

What the 93.846 tables omit

The Arthritis, Musculoskeletal and Skin Diseases Research hub lists award-backed obligations from USAspending.gov. It is not a trial registry, not a patient census, and not a publication index. Series that never appear as assistance awards will not show up in the $4,315,511,081.33. That omission is definitional rather than a gap in the 2,683 award rows.

Place-of-performance on 44 states is a coding field. Read the program page before treating those cells as equal shares. Recipient dollars, if shown on the hub, are still obligation amounts, not cash already spent on reagents or staff.

Where the 93.846 table lives

The Arthritis, Musculoskeletal and Skin Diseases Research program page overlays these four facts. The all-programs index ranks 93.846 among other assistance listings. Agency pages show awarding-agency rollups that may include this CFDA among other health-research listings. For 93.846 only, start on the program page.

CFDA 93.846’s 2,683 awards spread $4,315,511,081.33 across 365 recipients and 44 states. Quote award count as a record count, recipient count as the organizational headcount, and dollars as obligations from USAspending.gov. About 7.4 award records per recipient is the density story on this listing. Outlays remain a separate column. Source: USAspending.gov assistance awards.

CFDA 93.846 is indexed at $4,315,511,081.33 in obligations, 2,683 awards, 365 recipients, and 44 states on USAspending.gov. Arthritis, Musculoskeletal and Skin Diseases Research should be cited on that CFDA row alone. The $4.32 billion figure sizes the listing in the assistance file. It does not convert obligations into outlays, and it does not convert award count into a service, patient, student, or project census.

Readers who need the overlay tables should start on the program page for CFDA 93.846, then rank the listing on the all-programs index. Agency pages show awarding-agency rollups that may include this CFDA among other listings; they do not replace the $4,315,511,081.33 obligation stock. Keep the four facts together when quoting Arthritis, Musculoskeletal and Skin Diseases Research: dollars as obligations from USAspending.gov, award count as a stored-row count, recipient count as the organizational headcount (including 0 when the extract stores none), and the state figure as a geographic coding count.

Questions

How much is obligated for arthritis and musculoskeletal research?

USAspending.gov records $4,315,511,081.33 in obligations for CFDA 93.846. SpendingVault indexes 2,683 awards, 365 recipients, and 44 states. The figure is an obligation sum from assistance awards, not an outlay and not a patient count. CFDA 93.846’s $4.32 billion is the USAspending obligation stock.

How many awards does CFDA 93.846 carry?

The listing shows 2,683 awards against 365 recipients, or about 7.4 award records per recipient. A simple average is about $1.61 million per award. Award count is not a study or patient count. Recipient dollars are on the program page.

How many organizations receive 93.846 awards?

The extract lists 365 recipients. Those are organizational recipients on assistance awards tagged 93.846. Geographic coding covers 44 states. The packet does not name the 365 or publish scientific output. Recipient count is the organizational headcount. CFDA 93.846’s $4.32 billion on 2,683 awards, with 365 recipients and 44 states in this aggregate, is the USAspending obligation stock.

Is $4.32 billion already spent on this research?

Not necessarily. Obligations are commitments. Outlays are payments. CFDA 93.846’s indexed total is the obligation stock from USAspending.gov. This page does not report cash drawn, remaining balances, or research results. The $4.32 billion on 2,683 awards is the obligation figure.